BioAtla, Inc.
BCAB
$0.87
$0.045.18%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -41.82% | -51.29% | -34.46% | -48.62% | -42.27% |
| Gross Profit | -76.81% | 51.29% | 34.46% | 48.62% | 81.00% |
| SG&A Expenses | -27.66% | -14.05% | -6.17% | -21.63% | -11.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -38.08% | -15.13% | -27.98% | -43.08% | -36.41% |
| Operating Income | -22.35% | 15.13% | 27.98% | 43.08% | 67.82% |
| Income Before Tax | -49.05% | 11.20% | 34.00% | 44.72% | 68.23% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -49.05% | 11.20% | 34.00% | 44.72% | 68.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.05% | 11.20% | 34.00% | 44.72% | 68.23% |
| EBIT | -22.35% | 15.13% | 27.98% | 43.08% | 67.82% |
| EBITDA | -24.37% | 14.77% | 28.02% | 43.14% | 68.22% |
| EPS Basic | -22.65% | 26.82% | 45.53% | 46.57% | 68.57% |
| Normalized Basic EPS | -22.64% | 26.83% | 45.53% | 46.59% | 68.56% |
| EPS Diluted | -22.65% | 26.82% | 45.53% | 46.57% | 68.57% |
| Normalized Diluted EPS | -22.64% | 26.83% | 45.53% | 46.59% | 68.56% |
| Average Basic Shares Outstanding | 21.54% | 21.34% | 21.13% | 3.47% | 1.05% |
| Average Diluted Shares Outstanding | 21.54% | 21.34% | 21.13% | 3.47% | 1.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |